Target
bone stroma
1 abstract
Abstract
A feasibility study of 177Lu-PSMA radioligand therapy alternated with radium-223 in patients with bone-metastatic, oligo-metastatic, hormone-sensitive prostate cancer after curative therapy: The DUET study.Org: Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands, location VUMC, Netherlands Cancer Institute,